retatrutide 2025 trial results Retatrutide approval: FDA status, clinical trial results, and when it could be available Retatrutide—A Game Changer in Obesity

One thing to keep clear from the start

The functional composition of the diligence team should include patent attorneys with pharmaceutical litigation experience, PhD-level scientists with domain expertise in the relevant therapeutic area, FDA regulatory specialists who can verify exclusivity status and calculate Patent Term Extension eligibility, financial analysts who can translate legal findings into rNPV adjustments, and corporate development professionals who maintain the connection to the strategic rationale for the transaction

Key takeaways The list price for Wegovy is about $1,349 per month without insurance

It remains an investigational medicinal product (IMP) and has not been granted a marketing authorisation by the MHRA or the EMA (MHRA medicines licensing database, accessed April 2025

This reduction in calorie intake, and subsequent weight loss, is believed to be caused by a decrease in appetite and cravings and a reduction in cravings for high-fat foods

doi: 10.1056/NEJMoa1603827